Cartalax (20mg)
Original price was: $79.00.$59.00Current price is: $59.00.
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
Cartalax
Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid (sequence: Ala-Glu-Asp), supplied as a defined peptide test article for laboratory research. Due to its ultrashort sequence and natural amino-acid composition, it is frequently used in controlled in vitro studies involving peptide–cell interactions, extracellular matrix dynamics, and gene expression modulation.
Product Specifications
| Sequence | Ala-Glu-Asp (AED) |
| Molecular Formula | C12H19N3O8 |
| Molecular Weight | 333.29 g/mol |
| CAS Number | 87815447 (PubChem CID: 87815447) |
| Purity | ≥98% (HPLC verified) |
| Form | Lyophilized powder |
| Appearance | White to off-white powder |
Research Applications
- Chondrocyte and fibroblast culture assays examining extracellular matrix component expression (e.g., collagen and proteoglycan markers)
- Gene expression profiling in short-peptide exposure models to assess transcriptional changes
- Matrix remodeling pathway investigations involving matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) balances
- Cell signaling pathway screening for NF-ÎşB, p53, and related stress-associated cascades in controlled environments
- Peptide stability, degradation, and analytical method development (e.g., LC–MS profiling of AED and breakdown products)
Quality Documentation
Certificate of Analysis and HPLC chromatogram available for each lot.
For Laboratory Research Use Only
This product is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not for diagnostic, therapeutic, or clinical applications.
